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OBJECTIVE — To examine contraceptive practices among diabetic women and obese
women.
RESEARCH DESIGN AND METHODS — We analyzed the responses of 5,955 partic-
ipants aged 20–44 years in the 2002 National Survey for Family Growth. Diabetes, BMI, desire
for pregnancy, history of infertility treatment, sexual activity, parity, and demographic variables
(age, race/ethnicity, education, marital status, income, insurance, and smoking history) were
obtained by self-report. Lack of contraception was deﬁned as absence of hormonal-, barrier-, or
sterilization-based methods. Associations among contraception, diabetes, and BMI category
were assessed in multivariable logistic regression models in nonsterile, sexually active women.
RESULTS — In unadjusted comparisons among sexually active women who were not steril-
ized, women with diabetes were more likely to lack contraception than women without diabetes
(odds ratio [OR] 2.61 [95% CI 1.22–5.58]). Women with BMI 35 kg/m
2 were more likely to
lack contraception than women with BMI 25 kg/m
2 (1.63 [1.16–2.28]), but associations
between contraception use and lesser degrees of overweight and obesity were not signiﬁcant. In
multivariable models, women who were older (aged 30 vs. 20–29 years), were of non-
Hispanicblackrace,werecohabitating,hadahistoryofinfertilitytreatment,anddesiredorwere
ambivalent about pregnancy were signiﬁcantly more likely to lack contraception. The associa-
tionsamongdiabetes,BMI,andcontraceptionwerenolongersigniﬁcantaftertheseadjustments.
CONCLUSIONS — Older women with diabetes and obesity who desire pregnancy, regard-
less of pregnancy intention, should be targeted for preconceptive management.
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D
iabetes and obesity increasingly af-
fect women of reproductive age in
the U.S. (1,2). Data from the Na-
tional Health and Nutrition Examination
Survey show that the prevalence of phy-
sician-diagnosed diabetes in women aged
20 years was 7.1% from 2001 to 2004
(3). Moreover, in 2003–2004, one in
three women aged 20 years was identi-
ﬁed as obese (BMI 30 kg/m
2) (4).
Women with diabetes and those who are
obese are at increased risk for pregnancy
complications, including those from
surgical delivery, and their offspring are
at risk for congenital anomalies (5,6).
Women with diabetes can improve preg-
nancy outcomes by delaying pregnancy
until optimal glucose levels are reached
(7). Obese women are also at risk for ges-
tationaldiabetesmellitusandfutureonset
of diabetes (8,9). Effective family plan-
ning, used in conjunction with glucose
management for women with diabetes, as
well as weight loss and diabetes screening
before pregnancy, may reduce the risk to
the mother and fetus associated with dia-
betes and obesity. In addition, family
planning will reduce the risk of mistimed
pregnancies (10).
Between one-half and two-thirds of
women with diabetes have experienced
unplanned pregnancies (11–14). How-
ever,Chuangetal.(15)foundthatamong
sexuallyactivewomenwithdiabetes,only
a quarter reported no contraceptive use.
Similarly, reports of contraceptive prac-
ticesofobesewomenvary.WhileChuang
et al. (15) found that one-ﬁfth of poten-
tially fertile obese women reported no
contraceptiveuse,otherreports(16)have
found much lower rates of contraception
among obese women.
It is also not clear to what extent dia-
betes or obesity are independent risk
factors for contraception nonuse. The ob-
jective of this study was to examine con-
traceptive nonuse and its associations
with diabetes and categories of BMI using
data from the 2002 National Survey for
Family Growth (NSFG). We hypothe-
sized that women with diabetes would
report less contraceptive use than nondi-
abetic women and that this difference
would persist after adjustment for demo-
graphic factors and potential confound-
ers, such as desire for pregnancy, history
of infertility treatment, and obesity. We
also hypothesized that overweight and
obese women would report less frequent
contraceptive use than healthy-weight
women after adjustment for potential
confounders.
RESEARCH DESIGN AND
METHODS— The study population
was drawn from the 2002 NSFG, a peri-
odic survey designed and administered
by the National Center for Health Statis-
tics (NCHS). This survey is the principal
sourceofU.S.nationalestimatesoffactors
affecting pregnancy and birth rates, par-
ticularly contraceptive use and preg-
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Americanwomen,Latinas,andteenagers.
The 2002 survey was designed to obtain
detailed information on factors affecting
childbearing, marriage, and parenthood
from a national probability sample of
12,571 noninstitutionalized men and
women 15–44 years of age (n  7,643
nonpregnant women) (17). The survey
was administered using computer-
assisted personal interviewing. Trained
interviewers asked participants questions
and entered the responses into a note-
book computer. A detailed description of
the 2002 NSFG sample design and sam-
pling weights is provided elsewhere (17).
Our sample was comprised of non-
pregnant female respondents 20–44
yearsofagewithrecordedinformationon
bothdiabetesstatusandBMI(n5,955).
As the appropriate method to assess
weightforheightinsubjects20yearsof
age (standardized growth curves for age)
differs from the approach used to calcu-
late BMI in adults, subjects 20 years of
age were excluded from these analyses.
For all multivariable analyses, our sample
was further restricted to women who re-
ported having sexual intercourse in the
past 4 weeks and were not sterile (n 
3,822).Asthisanalysiswasconductedon
a deidentiﬁed public-use dataset, it was
classiﬁed as exempt by the University of
Michigan Institutional Review Board.
Dependent variable
Our outcome of interest was contracep-
tive nonuse at the time of the interview.
Participants were asked to list the types of
contraceptive methods that they were us-
ing at the time of the interview. Partici-
pants were classiﬁed as contraceptive
nonusers if they indicated that they were
not using a contraceptive method at the
time of interview. Contraceptive methods
were categorized as hormonal (including
birth control pills, injectables, implants,
intrauterine devices, and the contracep-
tive patch), barrier (including the male
condom, female condom, diaphragm,
cervical cap, and sponge), or sterilization.
Independent variables
Our primary exposures of interest were
diabetes status and BMI. Diabetes status
wasascertainedbasedonresponsestothe
following two questions: “Has a doctor or
other medical care provider ever told you
that you had diabetes or ‘sugar’?” and
“Were you ever told you had diabetes
when you were not pregnant?” (17). The
ﬁrst question was asked of all respon-
dents. The second question was only
asked to those who reported ever being
pregnant and responded “yes” to being
told that they had diabetes. Women were
categorized as having diabetes if they an-
swered “yes” to the ﬁrst question (if never
pregnant) or “yes” to both of these ques-
tions if they had ever been pregnant. Self-
report of preexisting (nongestational)
diabetes has a good concordance ()o f
0.8 when compared with medical record
reviews, with a sensitivity of 85% and
speciﬁcity of 97% (18).
All participants were asked to report
their height and weight at the time of in-
terview. Data cleaning was performed by
the NCHS staff to account for some ex-
tremely high and low values reported for
height and weight (based on the 5th and
95thpercentiles).Inparticular,heightfor
females was bottom coded at 60 to indi-
cate “60 inches or less” and top-coded at
70 to indicate “70 inches or more.”
Weight for females was bottom and top
coded at 108 and 240 lb, respectively
(17). For the purposes of this analysis,
BMI was recoded as a categorical variable
and consisted of the following levels: un-
derweight or normal weight (25.0 kg/
m
2),overweight(25.0–29.9kg/m
2),class
I obesity (30.0–34.9 kg/m
2), and class II
or III obesity (35 kg/m
2). Of note,
height is generally overestimated by an
average of 0.5 inches and weight is gener-
ally underestimated. However, the corre-
lation between measured weight and self-
reported weight exceeded 0.90 and
between measured height and self-
reported height was 0.92 in women in a
population-based survey (19).
Statistical analysis
Bivariate analyses were conducted to as-
certaindemographiccharacteristicsofthe
study population and to document varia-
tionsinfamily-planningpracticesaccord-
ing to diabetes status and BMI category.
The SURVEYFREQ procedure in SAS was
used to perform these analyses, and the
Rao-Scott modiﬁed 
2 test was applied to
test for statistical signiﬁcance at the P 
0.05 level.
The SURVEYLOGISTIC procedure in
SAS was used to assess the effect of diabe-
tesstatusandBMIcategoryontheoddsof
contraceptive nonuse in this study popu-
lation. Potential confounders were in-
cluded in the full model if they were risk
factors for contraceptive nonuse and as-
sociated with diabetes and/or BMI, based
on a P value 0.20. These covariates in-
cluded respondent age (20–29, 30–39,
or 40–44 years), race/ethnicity (non-
Hispanic white, non-Hispanic black, non-
Hispanic other, or Hispanic), educational
attainment (12, 12, or 12 years), total
household income ($20,000, $20,000–
34,999, $35,000–49,999, or $50,000
annually), marital status (never married,
cohabitating, married, or separated/
divorced/widowed), use of medical assis-
tancetobecomepregnant(yesorno),and
desire to become pregnant (yes, no, or do
not know). The NSFG assessed preg-
nancy intention only in women who were
not sterile. Among these women, preg-
nancy intention was assessed in married
or cohabitating women and among single
womenexpressingdesiretobecomepreg-
nant.Duetothesedifferentdenominators
and the stronger association between de-
sire and contraception than between in-
tention and contraception reported in
other analyses (20), we used desire for
pregnancy in a multivariate analysis,
although we reported both desire and
pregnancy intention in an unadjusted
analysis. Only those covariates that
changed the -coefﬁcient of either the di-
abetes or BMI variable by 10% were re-
tained in the ﬁnal model for all analyses.
For this analysis, the full and the ﬁnal
models remained the same.
All analyses were performed using
SAS version 9.1.3 for Windows (SAS In-
stitute, Cary, NC). For all analyses, the
data were weighted to adjust for the sur-
vey design, sampling, coverage, and re-
sponse rates so that accurate national
estimates can be made from the sample.
Thus, the ﬁndings presented can be gen-
eralized to all U.S. nonpregnant, nonin-
stitutionalized women 20–44 years of
age.
RESULTS— The study sample con-
sistedof135womenwithdiabetes(2.3%)
and 5,820 women without diabetes
(97.7%). Women with diabetes were
morelikelytobeolder,ofminoritystatus,
and to be separated, divorced, or wid-
owed than women without diabetes (Ta-
ble 1). Diabetic women reported higher
rates of receiving medical help to become
pregnant (13.0%) than women without
diabetes (9.7%), although differences
were not statistically signiﬁcant. Addi-
tionally, diabetic women were slightly
less likely to have been sexually active in
the past 4 weeks and less likely to desire
pregnancy and were more likely to report
surgical sterility than nondiabetic women.
Diabetic women reported a higher percent-
ageofcontraceptivenonusecomparedwith
Vahratian and Associates
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Diabetes BMI (kg/m
2)
Yes No
Under/normal
(25.0)
Overweight
(25.0–29.9)
Class I obese
(30.0–34.9)
Class II/III obese
(35.0)
n 135 5,820 3,028 1,522 795 610
Age (years)*†
20–29 15.8 36.1 41.1 29.9 33.3 25.3
30–39 41.7 40.8 37.7 44.2 43.0 45.6
40–44 42.5 23.1 21.2 25.9 23.7 29.1
Race and Hispanic origin*†
Non-Hispanic white 63.7 67.6 71.6 63.0 62.0 64.2
Non-Hispanic black 21.5 13.7 9.5 16.9 19.1 22.3
Non-Hispanic other 1.1* 5.1 6.5 3.6 3.6 3.0
Hispanic 13.7 13.6 12.4 16.5 15.3 10.5
Completed years of education†
12 13.9 15.0 13.2 17.1 15.5 18.6
12 29.6 20.5 18.1 21.6 25.6 25.7
12 56.5 64.5 68.7 61.3 58.9 55.7
Marital status*
Never married 18.1 25.0 26.7 21.8 22.8 24.7
Cohabitating 8.9 9.4 9.6 8.7 9.7 9.8
Married 48.5 53.7 52.5 56.3 54.0 52.3
Separated, divorced, or widowed 24.5 11.9 11.2 13.2 13.5 13.2
Total combined income, 2001 (USD)†‡
20,000 34.6 24.2 23.4 22.0 28.8 29.5
20,000–34,999 17.5 22.1 20.3 22.8 23.6 26.0
35,000–50,000 17.6 15.2 14.5 15.8 13.9 19.1
50,000 30.2 38.5 41.7 39.3 33.6 25.4
Health insurance coverage, 2001
Private or Medi-Gap 69.3 70.8 73.5 70.3 66.6 63.5
Medicaid, CHIP, or state sponsored 14.4 9.1 7.6 8.9 12.3 14.4
Other 3.6§ 3.2 3.2 3.3 2.8 3.7
Uninsured 12.7 16.7 15.5 17.5 18.2 17.9
Do not know/refused 0.0§ 0.1§ 0.1§ 0.02§ 0.0§ 0.4§
Tobacco use
Current (in past 12 months) 39.7 29.6 30.2 30.0 28.6 29.0
Past 10.4 11.8 11.3 10.7 14.1 14.4
Never 49.9 58.5 58.5 59.3 57.3 56.6
Previously pregnant†
Yes 80.0 74.2 69.3 80.0 79.5 79.7
No 20.2 25.8 30.7 20.0 20.5 20.3
Medical help to become pregnant
Yes 13.0 9.7 9.5 8.7 10.8 12.5
No 87.0 90.3 80.5 91.3 89.2 87.5
Pregnancy desire*
Yes 41.7 49.8 52.0 46.4 49.3 45.9
No 57.8 47.7 45.4 51.4 48.1 52.1
Do not know 0.5§ 2.5 2.6 2.2 2.6 2.0
Pregnancy intention 
Intend 62.7 63.5 65.4 61.3 58.6 64.3
Do not intend 37.3 33.7 32.2 35.1 39.4 32.8
Do not know 0.0§ 2.7 2.4 3.5 2.0§ 2.9§
Currently sexually active*†
Yes 77.2 87.1 88.1 87.7 86.0 79.7
No 22.8 12.9 11.9 12.3 14.0 20.3
Current contraceptive methods¶
None*† 38.8 27.3 28.0 25.2 25.3 33.0
Hormonal based*† 15.3 26.4 29.3 24.8 23.7 16.5
Continued on facing page
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spectively; P  0.05).
Overweight and obesity were more
common among older women than
among women aged 20–29 years and
among women who had less education,
lower income, and higher parity than
women with BMI 25 kg/m
2. Obese and
overweight women reported higher rates
of treatment for infertility than women
with BMI 25 kg/m
2, although these dif-
ferences were not statistically signiﬁcant.
Overweight and obese women were
slightly less likely to have been sexually
active in the past 4 weeks and to desire
pregnancy compared with women with
BMI25kg/m
2.Theassociationbetween
BMI and current contraceptive method
was statistically signiﬁcant.
Among sexually active women who
were nonsterile (n  3,822), the unad-
justed odds of contraceptive nonuse were
2.61timeshigherindiabeticwomenthan
in nondiabetic women (95% CI 1.22–
5.58) (Table 2). After adjusting for age,
race/ethnicity, education, marital status,
incomelevel,receiptofmedicalassistance
to become pregnant, desire to become
pregnant, and BMI, the odds of contracep-
tion nonuse decreased slightly in diabetic
women and were no longer statistically
signiﬁcant compared with women with-
out diabetes (adjusted odds ratio [OR]
1.84 [95% CI 0.81–4.19]).
Similarly, the unadjusted odds of
contraceptive nonuse were higher among
women with class II or III obesity, al-
though not for overweight women or
women with class I obesity. However, the
association between class II or III obesity
and lack of contraception did not persist
afteradjustmentforconfounders.Covari-
ates such as higher age, non-Hispanic
blackrace,historyofmedicalassistanceto
become pregnant, and the desire to be-
come pregnant were associated with lack
of contraception, while higher educa-
tional attainment and a cohabitation liv-
ing environment were associated with
contraception use.
CONCLUSIONS— In this nationally
representative, population-based survey
of nonpregnant women, we found that
40% of women with diabetes and up to
a third of women with elevated BMIs did
not use contraception. Among women
who were sexually active and nonsterile,
having diabetes was associated with more
than a twofold-greater odds of not using
contraception, while class II or III obesity
(BMI 35.0 kg/m
2) was associated with a
1.6-fold–greater odds of not using con-
traception. However, after adjustment for
confounders such as age, racial/ethnic
group,education,historyoffertilitytreat-
ment, and desire for pregnancy, neither
having diabetes nor being obese was sig-
niﬁcantly associated with contraceptive
nonuse. History of fertility treatment, de-
sire for pregnancy, and ambivalence
aboutpregnancywereassociatedwiththe
greatest odds of not using contraception.
Previous studies of unplanned preg-
nancies suggest low rates of contraceptive
use among women with diabetes, ranging
from roughly a quarter to half (11–14).
We found higher (although still subopti-
mal) rates of contraception use in this
sample. The difference between our re-
sultsandthosefrompreviousstudiesmay
be due to the fact that previous studies
surveyed women who were pregnant at
the time of interview, while the NSFG
sample that we used only included
women who were not pregnant at the
time of the interview.
In the Behavioral Risk Factor Surveil-
lance Study, Chuang et al. (15) found
similar rates of contraceptive use among
women with diabetes to those that we
documented. We also found that the ma-
jority of overweight and obese women
usedcontraception,similartotheirreport
(15). In our study, we further examined
the relationship between severity of obe-
sity and contraception and found that
contraception use was signiﬁcantly lower
among women with severe (class II or III)
obesity compared with women with
lesser degrees of overweight and obesity.
In other words, lesser degrees of obesity
were not a risk factor for lack of contra-
ception before or after adjustment for po-
tential confounders.
Diabetes and severe obesity were not
risk factors for lack of contraception after
adjustmentforotherconfoundersinclud-
inghistoryofinfertilitytreatment.Diabetes
and obesity are associated with conditions
inhibiting ovulation, such as polycystic
ovary disease, thus inhibiting pregnancy
and increasing the likelihood of infertility
(21). In our analysis, treatment for subfe-
cundity or infertility was associated with
lack of contraception, presumably due to
the assumption that contraception would
not be needed (22). However, women
may incorrectly perceive that they cannot
become pregnant; approximately half of
thesewomenwhowerehavingregularin-
tercoursereportednotusingbirthcontrol
Table 1—Continued
Diabetes BMI (kg/m
2)
Yes No
Under/normal
(25.0)
Overweight
(25.0–29.9)
Class I obese
(30.0–34.9)
Class II/III obese
(35.0)
Barrier† 11.1 15.8 17.6 14.9 13.1 11.1
Sterilization† 36.7 28.4 24.1 31.5 33.8 37.5
Other* 1.6§ 7.9 7.1 9.9 8.5 5.6
Female’s sterility status*†
Not sterile 55.8 75.5 81.0 72.0 66.9 62.3
Surgically sterile 36.3 22.3 16.7 26.1 31.0 34.3
Nonsurgically sterile 7.9 2.2 2.3 1.9 2.1 3.4
Partner’s sterility status
Not sterile 91.4 86.2 84.5 88.3 89.4 86.4
Surgically sterile 5.0§ 12.7 14.3 10.9 9.0 12.1
Nonsurgically sterile 3.6§ 1.1 1.2 0.8§ 1.6§ 1.5§
*Rao-Scott 
2 test, P  0.05, for diabetes. †Rao-Scott 
2 test, P  0.05, for BMI. ‡Data available for 5,664 (95%) of respondents. §Unweighted frequency was 10.
 Eligible respondents were physically able to have children. ¶Respondents could select up to three methods. Percentages do not sum to 100.
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get pregnant (22).
Desire for pregnancy and ambiva-
lence about pregnancy were associated
with greater risk of contraceptive nonuse.
While the obesity and diabetes literature
has focused on unintended pregnancy,
the family-planning literature has since
documentedthatdesireforpregnancyisa
better predictor of family-planning prac-
tices than “intendedness” of pregnancy
(23). Pregnancies may be unplanned but
desired(20).Thisdistinctionmayexplain
the lack of contraception in some women
who do not intend to become pregnant
immediately and may explain why some
women do not engage in recommended
preconceptionpractices,suchasuseoffam-
ily planning until optimal glycemic control
is reached. As women with diabetes were
less likely to desire pregnancy than nondia-
betic women, adjustment for this variable
may have strengthened the association be-
tween diabetes and lack of contraception,
although the association remained nonsig-
niﬁcant. Clinicians caring for women with
diabetes and/or elevated BMIs may target
women who desire pregnancy or who feel
ambivalent about pregnancy for more in-
tensivepreconceptionmanagement,evenif
thesewomendonotintendtogetpregnant.
Such management may be more successful
if focused on supportive measures and
more intensive glucose control, rather than
family planning (11).
As with other studies (22), we found
that older women were at risk for lack of
contraception, even after adjustment for
other factors. We found that this was true
forwomenaged30–39yearsaswellasfor
women aged 40 years. While it is true
that fertility declines with age, women in
their 30s and early 40s may still conceive
spontaneously. It is possible that women
believe that declines in fertility negate the
need for contraception. We also found
that African American women were less
likely to use contraception, even after ad-
justment for other potential confounders
suchasage,maritalstatus,andeducation.
Previous reports have speculated that
these differences may be due to race-
speciﬁc beliefs about the risks and bene-
ﬁts of different types of contraception,
particularly hormonal contraception
(24). Of note, cohabitation was also asso-
ciated with greater contraception use,
whilemaritalstatuswasnot.Whileexpla-
nations are speculative, women who co-
habit may have greater frequency of
intercourse than their single counterparts
but also may have less social support for
pregnancy than their married counter-
parts (22).
Strengths of this report include the
population-based nationally representa-
tive sample and the available information
on pregnancy desire, fertility treatment,
previous pregnancy, and demographic
variables, all of which are associated with
contraceptiveuse.Limitationsincludelit-
tle information on reasons for contracep-
tive nonuse, particularly with respect to
reasons speciﬁc to chronic disease, diabe-
tes, and obesity. Additionally, we are un-
able to determine from the NSFG data
how long women have had diabetes or
whether they have type 1 or type 2 diabe-
tes. Information about perceived risks of
hormonal contraception for glucose con-
trol, intention to lose weight, ineligibility
for particular methods, and lack of effec-
tiveness of hormonal methods due to
weight would have added to these analy-
ses. Finally, the NSFG does not inquire
about other factors related to health care
delivery, such as usual source of care; it is
possible that a lack of a usual source of
caremayserveasabarriertothereceiptof
family-planning services.
We conclude that the use of contra-
ception is not optimal among women
with diabetes and elevated BMI. How-
ever, our ﬁndings suggest that the lack of
Table 2—Unadjusted and adjusted ORs and 95% CIs for contraceptive nonuse among women
at risk for pregnancy
Unadjusted OR (95% CI) Adjusted OR (95% CI)*
Age (years)
20–29 1.00 1.00
30–39 1.18 (0.98–1.42) 1.47 (1.19–1.82)
40–44 1.40 (0.90–2.17) 2.61 (1.61–4.22)
Race and Hispanic origin
Non-Hispanic white 1.00 1.00
Non-Hispanic black 1.90 (1.48–2.44) 1.76 (1.34–2.30)
Non-Hispanic other 0.99 (0.68–1.46) 1.07 (0.74–1.55)
Hispanic 1.37 (1.02–1.83) 1.19 (0.90–1.59)
Completed years of education
12 1.03 (0.68–1.55) 1.01 (0.66–1.54)
12 1.00 1.00
12 0.61 (0.43–0.86) 0.56 (0.38–0.82)
Marital status
Never married 1.00 1.00
Cohabitating 0.74 (0.52–1.04) 0.67 (0.47–0.96)
Married 0.88 (0.68–1.14) 0.80 (0.61–1.05)
Separated, divorced, or widowed 1.35 (0.98–1.86) 1.09 (0.77–1.53)
Total combined income, 2001 (USD)
20,000 1.00 1.00
20,000–34,999 0.77 (0.60–0.99) 0.86 (0.66–1.12)
35,000–49,999 0.83 (0.49–1.40) 0.89 (0.56–1.43)
50,000 0.68 (0.51–0.89) 0.73 (0.54–1.00)
Medical help to become pregnant
Yes 3.14 (2.37–4.18) 3.32 (2.35–4.70)
No 1.00 1.00
Pregnancy desire
Yes 1.54 (1.17–2.03) 2.27 (1.79–2.88)
No 1.00 1.00
Do not know 1.51 (0.63–3.60) 2.20 (1.05–4.59)
Diabetes status
Diabetic 2.61 (1.22–5.58) 1.84 (0.81–4.19)
Nondiabetic 1.00 1.00
BMI (kg/m
2)
25.0 1.00 1.00
25.0–29.9 1.03 (0.80–1.32) 0.91 (0.68–1.20)
30.0–34.9 1.05 (0.79–1.39) 0.89 (0.66–1.19)
35.0 1.63 (1.16–2.28) 1.30 (0.87–1.94)
*Models were adjusted for all variables shown in this table.
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risk groups is related to sociodemo-
graphicfactorsandotherfactorsrelatedto
pregnancy and not these conditions per
se. Efforts to improve family-planning
practices could address factors associated
withcontraceptiveuse,particularlywom-
en’s beliefs about fecundity, speciﬁc to
age and history of fertility treatment, as
wellasambivalenceabouttheirdesiresfor
pregnancy. If future pregnancies are de-
sired,preconceptionmanagementmaybe
more successful if daily folic acid use,
weight management, and glycemic con-
trol are addressed in these clinical discus-
sions instead of focusing solely on
initiation of family planning, even if preg-
nancy is not immediately intended. Fu-
ture research is needed that focuses on
interventions targeting these factors, par-
ticularlyinpopulationsaged30–39years
and women with diabetes, and interac-
tions with health care delivery.
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